Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof

A gene and genetic engineering technology, used in the preparation of fibrinolytic drugs and the field of embolic diseases, can solve the problems of low market share, inability to clarify, toxic and side effects, and achieve huge social and economic benefits and good thrombolytic effect. , the effect of less bleeding

Inactive Publication Date: 2005-02-23
SUN YAT SEN UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, there are regional and seasonal variations in the composition and biological activity of natural-sourced five-step snake venom, and it is actually difficult to obtain stable clinical curative effect; in addition, due to the complex composition of crude snake venom, it is still difficult to purify it. Obtaining a truly single chemical composition makes clinical application imply certain toxic and side effects; the production of natural snake venom is limited, the cost is high, and the market share is low; its molecular structure and the relationship between structure and activity cannot be clarified by protein technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof
  • Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof
  • Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] 1. Separation of fibrinolytic factor FII from snake venom in five steps

[0039] 1. DEAE-Sephadex A-50 ion exchange chromatography

[0040] Method: DEAE-Sephadex A-50 ion-exchange gel was rinsed repeatedly in 0.05M ammonium acetate buffer with pH 8.0, soaked at 25°C for about 24 hours, and then packed into a column (gel column diameter 2.6cm, height 100cm). When the pH value of the effluent is close to 8.0, the balance is completed. 3g of five-step snake venom crude venom is dissolved in 10ml of 0.05M ammonium acetate buffer solution with a pH of 8.0, centrifuged at 1500rpm for 15 minutes to remove sediment, and then put on the column. Use 750ml of 0.05M pH8.0 ammonium acetate buffer and 1M pH5.0 ammonium acetate buffer for linear gradient elution, and the eluent collection rate is 4tube / h, 3ml / tube. Light absorption values ​​were measured at a wavelength of 280 nm. The fibrinolytic activity of each peak was measured, and the components with fibrinolytic activity were...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Login to View More

Abstract

A snake soluble fibrinous No.2 gene, carrier containing the gene, gene engineering xenological cell by the carrier, medicine for preparing albuminoid and treating embolic disease by the carrier are disclosed. It includes: separating snake venoms from fibrinolytical factor FII; screening and cloning fibrinolytical factor FII; expressing fibrinolytical factor FII yeast cell; purifying expressive product and determining fibrinolytical activity. It achieves low cost, high output and good quality.

Description

[technical field] [0001] The invention relates to the technical field of genetic engineering, in particular to the No. 2 gene of Agkistrodon akistrodon (pentapod venom) dissolving fibrin (original), a carrier containing the gene, a host cell genetically engineered by using the carrier and the The gene is used to prepare medicines for dissolving fibrin (ogen) to resist embolism diseases caused by thrombus formation. [Background technique] [0002] Embolism diseases caused by intravascular thrombosis, especially myocardial infarction and cerebral apoplexy, are currently the most harmful diseases to human health in the world, and their morbidity and fatality rates rank first among all diseases. In my country, with the control of most infectious diseases, the significant improvement of people's living standards, the general extension of population life expectancy and the development of population aging, the incidence of heart and cerebrovascular thrombosis has risen to The first...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61K38/36A61P9/00C07H21/04C07K14/75C12N15/12C12N15/63
Inventor 颜光美陈家树邱鹏新单鸿
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com